Back
Minerva Neurosciences Vs. ACADIA Pharmaceuticals Industry Stock Comparison
Sell
45
NERV
Minerva Neurosciences
Last Price:
2.50
Seasonality Move:
22.08%
Sell
49
ACAD
ACADIA Pharmaceuticals
Last Price:
17.07
Seasonality Move:
7.01%
Sell
45
Minerva Neurosciences (NERV)
is a Sell
Is Minerva Neurosciences a Buy, Sell or Hold?
- The current Minerva Neurosciences [NERV] share price is $2.51. The Score for NERV is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NERV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $17.13. The Score for ACAD is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NERV Stock Price Chart
What is Minerva Neurosciences's stock price today?
-
The Minerva Neurosciences share price today is $2.51
The current trend is relatively stagnant and NERV is experiencing slight buying pressure.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $17.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing slight selling pressure.
NERV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 44.13 | Sell |
| Chaikin Money Flow: | 3130 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ACAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.47 | Sell |
| Relative Strength Index (14 RSI): | 43.05 | Sell |
| Chaikin Money Flow: | -112328 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.7 - 17.62) | Sell |
| Bollinger Bands (100): | (18.22 - 28.3) | Sell |
NERV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.4 | Buy |
| 20-day SMA: | 2.45 | Buy |
| 50-day SMA: | 2.56 | Sell |
| 200-day SMA: | 6.06 | Sell |
| 8-day EMA: | 2.43 | Buy |
| 20-day EMA: | 2.49 | Buy |
| 50-day EMA: | 3.22 | Sell |
| 200-day EMA: | 5.15 | Sell |
ACAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.04 | Buy |
| 20-day SMA: | 16.97 | Buy |
| 50-day SMA: | 18.76 | Sell |
| 200-day SMA: | 23.95 | Sell |
| 8-day EMA: | 17.05 | Buy |
| 20-day EMA: | 17.25 | Sell |
| 50-day EMA: | 18.95 | Sell |
| 200-day EMA: | 22.31 | Sell |
Minerva Neurosciences Earnings Growth & NERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.17 per share, an increase this year of $2.49 per share, and a decrease next year of $1.83 per share.
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, an increase next quarter of $0.07 per share, an increase this year of $0.99 per share, and an increase next year of $0.60 per share.
Minerva Neurosciences Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ACADIA Pharmaceuticals Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||